Accordingly, presence of detectable JCV-specific CD8+ T cells in peripheral blood correlates with improved prognosis and survival in PML patients (36–38), whereas anti-JCV humoral responses do not (39, 40). This evidence concerns the gene CD8A and progressive multifocal leukoencephalopathy.